This approximately 21,900 sq. ft. (2,035 m2) manufacturing facility develops products using Eurand’s proprietary Diffucaps® and Microcaps® technologies. It supplies products to the European and Middle Eastern markets.
Pharmaceutical technologies for formulation development and life cycle management solutions.
Click Now